CD86 and neoplasm: DC maturation in the TME can be promoted by HMGB1 stimulated by preoperative chemoradiotherapy and is accompanied by surface molecule (CD80, CD86, CD208, and LAMP3) expression with anti-tumor functions of tumor-associated antigen presentation, which facilitates effective CD8+ T cell activation.